$350.56−6.38 (−1.79%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
Cencora (COR) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~10.7%/yr (FY21→FY25), net margin 0.5%, and free cash flow (~$3.2B) tracks net income. Earnings are cash, not paper.
The four lines that matter · FY21–FY25
Revenue ($B)▲9.3%
321.3
FY21→FY25CAGR +10.7%/yr
Net income ($B)▲3.0%
1.6
FY21→FY25CAGR +0.2%/yr
Free cash flow ($B)▲7.0%
3.2
FY21→FY25CAGR +9.5%/yr
Diluted EPS▲5.7%
7.96
buyback-liftedCAGR +1.9%/yr
What the receipts whisper · what a headline number hides
Share count
−6.4%
208.5mn → 195.2mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$668.0M
+37.1% YoY in FY25 · 0.2% of revenue.
Returns vs FCF
27%
$0.9B returned vs $3.2B of FCF in FY25. Buybacks + dividends covered by cash flow.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($B)
0¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 3.2% → 3.6%. Net margin 0.5% is below the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 332,771.3 | 321,332.8 | 293,958.6 | 262,173.4 | 238,587.0 | 213,988.8 | ▲9.3% | +10.7% |
Cost of revenue | 319,550.1 | 309,854.3 | 284,048.6 | 253,213.9 | 230,290.6 | 207,045.6 | ▲9.1% | +10.6% |
Gross profit | 13,221.2 | 11,478.5 | 9,910.0 | 8,959.5 | 8,296.4 | 6,943.2 | ▲15.8% | +13.4% |
Selling, general & admin | 7,654.2 | 6,493.8 | 5,661.1 | 5,310.0 | 4,849.0 | 3,594.3 | ▲14.7% | +15.9% |
Total operating expenses | 10,179.5 | 8,849.9 | 7,734.8 | 6,618.8 | 5,930.0 | 4,589.0 | ▲14.4% | +17.8% |
Operating incomefeeds ROC rank | 3,041.8 | 2,628.6 | 2,175.2 | 2,340.7 | 2,366.4 | 2,354.2 | ▲20.8% | +2.8% |
Other income, net | 564.8 | −370.3 | −171.3 | −179.9 | −183.3 | −132.3 | — | — |
Pretax income | 3,606.6 | 2,258.3 | 2,004.0 | 2,160.8 | 2,183.1 | 2,221.9 | ▲12.7% | +0.4% |
Income tax | 967.3 | 690.5 | 484.7 | 428.3 | 516.5 | 677.3 | ▲42.5% | +0.5% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 2,624.8 | 1,554.2 | 1,509.1 | 1,745.3 | 1,698.8 | 1,544.6 | ▲3.0% | +0.2% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 13.47 | 7.96 | 7.53 | 8.53 | 8.04 | 7.39 | ▲5.7% | +1.9% |
Diluted shares (mn) | 193.94 | 195.21 | 200.28 | 204.59 | 211.21 | 208.47 | ▼2.5% | −1.6% |
| Margins | ||||||||
Gross margin2nd pct in Healthcare | 4.0% | 3.6% | 3.4% | 3.4% | 3.5% | 3.2% | ▲0.2pp | +0.3pp |
Operating margin | 0.9% | 0.8% | 0.7% | 0.9% | 1.0% | 1.1% | ▲0.1pp | −0.3pp |
Net margin42nd pct in Healthcare | 0.8% | 0.5% | 0.5% | 0.7% | 0.7% | 0.7% | ▼0.0pp | −0.2pp |
† TTM = trailing four quarters through 2026-06-30.
5 more years of statements and CSV export are on Premium, and 14 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2025-11-25 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Cencora's revenue last fiscal year?
Cencora reported revenue of $321.3B in fiscal 2025, up 9.3% from fiscal 2024.
What was Cencora's net income?
Cencora reported net income of $1.6B in fiscal 2025, a net margin of 0.5%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

